Rx Shorts: August 2018

The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

Opill OTC has significantly increased contraceptive use and shifts from less effective options among women who are uninsured, of racial/ethnic minorities, and live in the rural US.

August 15th 2025

Fewer Than 1 in 4 Women Maintain Optimal CV Health in Menopause: Daily Dose

Explore the latest insights on diabetes in pregnancy, asthma management disparities, AI in health care, dementia risk reduction, and new eczema treatments.

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Your daily dose of the clinical news you may have missed.

August 7th 2025

Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Public Awareness of HPV and HPV Vaccine Remains Low, Especially in Midwest and South, Study Finds

The statistically significant improvements seen in key HS symptoms during GLP-1 treatment for obesity suggest overlap in both mechanistic and immunologic effects.

OTC Contraception Option Improves Access For Women at High Risk for Unintended Pregnancy

New data shows more than one-third of US adults are unaware of HPV or the HPV vaccine, with gaps greatest in the Midwest and South, where HPV-related cancers are most common.

Related Content

The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

Opill OTC has significantly increased contraceptive use and shifts from less effective options among women who are uninsured, of racial/ethnic minorities, and live in the rural US.

August 15th 2025

Fewer Than 1 in 4 Women Maintain Optimal CV Health in Menopause: Daily Dose

Explore the latest insights on diabetes in pregnancy, asthma management disparities, AI in health care, dementia risk reduction, and new eczema treatments.

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Your daily dose of the clinical news you may have missed.

August 7th 2025

Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists

Insights on atopic dermatitis treatment preferences, the safety of childhood vaccines, maternal depression’s effect on parenting, and more.

Public Awareness of HPV and HPV Vaccine Remains Low, Especially in Midwest and South, Study Finds

The statistically significant improvements seen in key HS symptoms during GLP-1 treatment for obesity suggest overlap in both mechanistic and immunologic effects.